Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Multicenter, Open-label, Phase III Study of Plitidepsin in Combination With Dexamethasone vs. Dexamethasone Alone in Patients With Relapsed/Refractory Multiple Myeloma

NCT01102426 is registered in ClinicalTrials.gov with PharmaMar as lead sponsor.

NCT NCT01102426
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01102426 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Multicenter, Open-label, Phase III Study of Plitidepsin in Combination With Dexamethasone vs. Dexamethasone Alone in Patients With Relapsed/Refractory Multiple Myeloma
Lead sponsor
PharmaMar
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2010
Completion date
November 30, 2017
Enrollment
255 (actual)
Sites
82

Conditions

As the registry lists them; a condition with its own page is linked.

relapsed/refractory multiple myeloma